CancerLinQ LLC, a wholly-owned nonprofit subsidiary of the American Society of Clinical Oncology, and the Oncology Nursing Society announced the formation of the CancerLinQ Ambassadors Program.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
